Literature DB >> 1421348

The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989.

V Romanus1, A Svensson, H O Hallander.   

Abstract

In April 1975, the mass vaccination of newborns against tuberculosis was replaced by selective vaccination of groups at risk. BCG coverage fell from more than 95% before 1974 to 1.8% between 1975 and 1982 and thereafter reached an average of 13.7% up to 1989. The cumulative incidence of tuberculosis before 5 years of age was estimated among children born in Sweden during periods of high, low and moderate increasing BCG coverage. The incidence figures per 100,000 children was 0.8, 3.9 and 2.9, respectively, for children born to Swedish parents and 2.6, 39.4 and 13.2, respectively, for those born to foreign parents. The observed incidence of tuberculosis among non-BCG vaccinated children born to Swedish parents was within the expected limits given by a prognostic model based on the natural change of the risk of infection. The effectiveness of the selective BCG vaccination programme, which was intensified after 1981 for the second generation of immigrants, was estimated to 0.82 (95% confidence interval 0.38, 0.95) assuming that there was no change of the risk of infection for children born to foreign parents over the period studied. From April 1975 to December 1989, tuberculosis was notified in 85 children born in Sweden during the same period, 7 of them were BCG vaccinated and 78 non-vaccinated, 45 were symptomatic, 3 of them with disseminated tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1421348     DOI: 10.1016/0962-8479(92)90149-E

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  9 in total

1.  "To BCG or not to BCG, that is the question!". The challenge of BCG vaccination: Why can't we get it right?

Authors:  Wendy Vaudry
Journal:  Paediatr Child Health       Date:  2003-03       Impact factor: 2.253

2.  The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination.

Authors:  G Dahlquist; L Gothefors
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

3.  Infant tuberculosis in Austria--trend reversal since 1990?

Authors:  A Makristathis; F Stauffer; J P Klein; M L Rotter; G Wewalka; A M Hirschl
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

4.  Protective effect of neonatal BCG vaccines against tuberculous meningitis.

Authors:  Sandra Puvacić; Jadranka Dizdarević; Z Santić; M Mulaomerović
Journal:  Bosn J Basic Med Sci       Date:  2004-02       Impact factor: 3.363

5.  Mycobacterial species causing pulmonary tuberculosis at the korle bu teaching hospital, accra, ghana.

Authors:  Kk Addo; K Owusu-Darko; D Yeboah-Manu; P Caulley; M Minamikawa; F Bonsu; C Leinhardt; P Akpedonu; D Ofori-Adjei
Journal:  Ghana Med J       Date:  2007-06

6.  Evaluating the neonatal BCG vaccination programme in Ireland.

Authors:  Cara Usher; Roisin Adams; Susanne Schmitz; Jennifer Kieran; Darina O'Flanagan; Joan O'Donnell; Kevin Connolly; Brenda Corcoran; Karina Butler; Michael Barry; Cathal Walsh
Journal:  Arch Public Health       Date:  2016-07-13

7.  Paediatric tuberculosis during universal and selective Bacillus Calmette-Guérin vaccination policy: a nationwide population-based retrospective study, Finland, 1995-2015.

Authors:  Antti Kontturi; Satu Kekomäki; Hanna Soini; Jukka Ollgren; Eeva Salo
Journal:  Euro Surveill       Date:  2021-03

8.  Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study.

Authors:  Sam Abbott; Hannah Christensen; Ellen Brooks-Pollock
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

9.  Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.

Authors:  Sam Abbott; Hannah Christensen; Nicky J Welton; Ellen Brooks-Pollock
Journal:  Euro Surveill       Date:  2019-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.